Evidence map›Paper›PMID 30593834›Full record

ArticleNeurobiology of disease2019

Rho-kinase inhibition has antidepressant-like efficacy and expedites dendritic spine pruning in adolescent mice.

Lauren P Shapiro, Henry W Kietzman, Jidong Guo, Donald G Rainnie, Shannon L Gourley

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lauren P ShapiroMolecular and Systems Pharmacology, Emory University, Atlanta, GA, United States; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States.
Henry W KietzmanDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States; Graduate Program in Neuroscience, Emory University, Atlanta, GA, United States.
Jidong GuoYerkes National Primate Research Center, Emory University, Atlanta, GA, United States; Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, United States.
Donald G RainnieYerkes National Primate Research Center, Emory University, Atlanta, GA, United States; Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, United States.
Shannon L GourleyMolecular and Systems Pharmacology, Emory University, Atlanta, GA, United States; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States; Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States; Graduate Program in Neuroscience, Emory University, Atlanta, GA, United States; Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, United States. Electronic address: shannon.l.gourley@emory.edu.
Emory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
ENNCF - Viral Vector CoreP30NS055077 · NINDS · EMORY UNIVERSITY · PI RESSLER, KERRY J. · 2008 to 2018
$6.8M
Stress-Induced Gene Regulation: BNST CRF Neurons and the Physiology of AnxietyR01MH072908 · NIMH · EMORY UNIVERSITY · PI YOUNG, LARRY J · 2005 to 2020
$6.0M
Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Orbitofrontal cortical coordination of action-consequence decision makingR01MH117103 · NIMH · EMORY UNIVERSITY · PI GOURLEY, SHANNON LEIGH · 2018 to 2022
$2.3M
Ontogenic factors in adolescent-emergent depression and decision-makingR01MH101477 · NIMH · EMORY UNIVERSITY · PI GOURLEY, SHANNON LEIGH · 2013 to 2017
$2.2M
Integrated mechanisms for orbitofrontal cortical control of memory and choiceR37MH117103 · NIMH · EMORY UNIVERSITY · PI Shannon Leigh Gourley · 2024 to 2026
$2.0M
Developing cytoskeletal-based interventions for adolescent-onset depressionF31MH109208 · NIMH · EMORY UNIVERSITY · PI SHAPIRO, LAUREN PAIGE · 2016 to 2018
$132k
NCATS NIH HHS UL1 TR002378NIGMS NIH HHS T32 GM008169NIGMS NIH HHS T32 GM008602NIH HHS P51 OD011132NIMH NIH HHS F31 MH109208NIMH NIH HHS R01 MH072908NIMH NIH HHS R01 MH101477NIMH NIH HHS R01 MH117103NIMH NIH HHS R37 MH117103NINDS NIH HHS P30 NS055077
6 · The paper itself

Abstract

Adolescence represents a critical period of neurodevelopment, defined by structural and synaptic pruning within the prefrontal cortex. While characteristic of typical development, this structural instability may open a window of vulnerability to developing neuropsychiatric disorders, including depression. Thus, therapeutic interventions that support or expedite neural remodeling in adolescence may be advantageous. Here, we inhibited the neuronally-expressed cytoskeletal regulatory factor Rho-kinase (ROCK), focusing primarily on the clinically-viable ROCK inhibitor fasudil. ROCK inhibition had rapid antidepressant-like effects in adolescent mice, and its efficacy was comparable to ketamine and fluoxetine. It also modified levels of the antidepressant-related signaling factors, tropomyosin/tyrosine receptor kinase B and Akt, as well as the postsynaptic marker PSD-95, in the ventromedial prefrontal cortex (vmPFC). Meanwhile, adolescent-typical dendritic spine pruning on excitatory pyramidal neurons in the vmPFC was expedited. Further, vmPFC-specific shRNA-mediated reduction of ROCK2, the dominant ROCK isoform in the brain, had antidepressant-like consequences. We cautiously suggest that ROCK inhibitors may have therapeutic potential for adolescent-onset depression.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAnimalsAntidepressive AgentsMiceMice, Inbred C57BLNeuronal PlasticityPrefrontal CortexProtein Kinase Inhibitorsrho-Associated Kinases1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAntidepressive AgentsfasudilProtein Kinase Inhibitorsrho-Associated KinasesForced swimHA-1077Novelty suppressed feedingProtein kinase BRho-associated coiled-coil containing kinaseROCKIISlx-2119

Identifiers

PMID30593834
PMCPMC6365018
OpenAlexW2906615611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.